En Es
Categories

Industry News

Researchers Develop AI Algorithm to Predict Immunotherapy Response

By Medimaging International staff writers
12 Sep 2018

Image: Researchers have designed an AI algorithm that uses CT scan images to process medical images and extract biological and clinical information (Photo courtesy of iStock).A team of French researchers have designed an algorithm and developed it to analyze Computed Tomography (CT) scan images, establishing for the first time that artificial intelligence (AI) can process medical images to extract biological and clinical information. The researchers have created a so-called radiomic signature, which defines the level of lymphocyte infiltration of a tumor and provides a predictive score for the efficacy of immunotherapy in the patient.

In the near future, this could make it possible for physicians to use imaging to identify biological phenomena in a tumor located anywhere in the body without performing a biopsy.

Currently, there are no markers, which can accurately identify patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. The more immunologically richer the tumor environment (presence of lymphocytes), the higher is the chances of immunotherapy being effective. Hence, the researchers tried to characterize this environment using imaging and correlate this with the patients’ clinical response. In their study, the radiomic signature was captured, developed and validated genomically, histologically and clinically in 500 patients with solid tumors (all sites) from four independent cohorts.

The researchers first used a machine learning-based approach to teach the algorithm how to use relevant information extracted from CT scans of patients participating in an earlier study, which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumor, thus establishing a radiomic signature.

The researchers tested and validated this signature in other cohorts, including that of TCGA (The Cancer Genome Atlas), thus demonstrating that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumor. Further, in order to test the signature’s applicability in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in five phase I trials of anti-PD-1/PD-L1 immunotherapy. The researchers found that the patients in whom immunotherapy was effective at three and six months had higher radiomic scores as did those with better overall survival.

In their next clinical study, the researchers will assess the signature both retrospectively and prospectively, using a larger number of patients and stratifying them based on cancer type in order to refine the signature. They will also use more sophisticated automatic learning and AI algorithms to predict patient response to immunotherapy, while integrating data from imaging, molecular biology and tissue analysis. The researchers aim to identify those patients who are most likely to respond to treatment, thereby improving the efficacy/cost ratio of treatment.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

06 Jul 2019
ACR Expands Pilot Program Focused on AI and Radiology
Radiology professionals from seven renowned health care institutions will use the ACR AI-LAB to demonstrate the process of creating investigational artificial intelligence (AI) models from image data without the use of a programming language.
Read More
06 Jul 2019
Konica Minolta Offers AI-Based Cardiac Ultrasound Analysis
Konica Minolta Healthcare Americas Inc, a provider of medical diagnostic imaging and healthcare information technology, has announced a partnership with DiA Imaging Analysis, a provider of artificial intelligence (AI) powered ultrasound analysis solutions.
Read More
06 Jul 2019
VR and AI Drive Exponential Growth in Integrated Operating Rooms
The operating room (OR) is transforming from a seemingly simple box into a technology-powered, infection-free, and sleek surgical environment.
Read More
06 Jul 2019
AI-Based Image Reconstruction Solution Receives FDA Clearance
Canon Medical Systems USA, Inc. has received 510(k) clearance from the FDA for its new deep convolutional neural network (DCNN) image reconstruction technology.
Read More
06 Jul 2019
Bracco Imaging Acquires Blue Earth Diagnostics to Expand Portfolio
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company.
Read More
06 Jul 2019
AI Approach Lowers Radiation Exposure from CT Imaging
Engineers at the Rensselaer Polytechnic Institute worked along with radiologists at Massachusetts General Hospital and Harvard Medical School to demonstrate that machine learning has the potential to vastly advance medical imaging, particularly computerized tomography (CT) scanning, by reducing radiation exposure and improving image quality.
Read More
06 Jul 2019
New AI-based Method Detects Brain Response to MS Treatment
Researchers at University College London and King's College London have developed a new artificial intelligence (AI)-based method for detecting the brain's response to treatment in multiple sclerosis (MS).
Read More
06 Jul 2019
Global Molecular Diagnostics Market to Reach USD 13.87 Billion by 2025
The global molecular diagnostics market was valued at USD 8 billion in 2017 and is projected to grow at a CAGR of 7.1% during the period 2018 to 2025 to reach USD 13.87 billion by 2025.
Read More
06 Jul 2019
Global Surgical Imaging Market to Reach USD 1.49 Billion by 2026
The global surgical imaging market was estimated to be worth USD 1.06 billion in 2018 and is projected to grow at a CAGR of 4.3% during the period 2019–2026 to reach USD 1.49 billion by 2026.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions